Therefore, these results showed that, in metastatic MCC patients treated with the PD-L1-inhibitor avelumab, BMI ≥ 30 and PLT ≥ 207 × 109/L were significant independent prognostic factors for longer PFS. Here, CD274 is linked to Merkel cell skin cancer.